No profile data available.
Cuprina Holdings (Cayman) Limited (CUPR) is a healthcare company in the healthcare consumable products industry, based in Singapore, Singapore, with about 14 full-time employees.
It reported revenue of 48,321 SGD for fiscal year 2024, down 52.0% from fiscal year 2023, and net income of -1.56 million SGD. Its market capitalization was $13.94 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
Cuprina Holdings (Cayman) reported 48,321 SGD in revenue for fiscal year 2024, down 52.0% from 100,773 SGD in fiscal year 2023.
$13.94 million as of December 4, 2025.
Listed companies of a similar size in the same industry (healthcare consumable products) include Jin Medical International Ltd. (ZJYL), Nuo Therapeutics, Inc. (AURX), Sanuwave Health, Inc. (SNWV), United Health Products, Inc. (UEEC).